These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26108143)

  • 1. Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations.
    Hossain MA; Higaki K; Saito S; Ohno K; Sakuraba H; Nanba E; Suzuki Y; Ozono K; Sakai N
    J Hum Genet; 2015 Sep; 60(9):539-45. PubMed ID: 26108143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.
    Lee WC; Kang D; Causevic E; Herdt AR; Eckman EA; Eckman CB
    J Neurosci; 2010 Apr; 30(16):5489-97. PubMed ID: 20410102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
    Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
    Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
    Suzuki Y
    Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.
    Higaki K; Li L; Bahrudin U; Okuzawa S; Takamuram A; Yamamoto K; Adachi K; Paraguison RC; Takai T; Ikehata H; Tominaga L; Hisatome I; Iida M; Ogawa S; Matsuda J; Ninomiya H; Sakakibara Y; Ohno K; Suzuki Y; Nanba E
    Hum Mutat; 2011 Jul; 32(7):843-52. PubMed ID: 21520340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
    Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
    Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts.
    Hossain MA; Higaki K; Shinpo M; Nanba E; Suzuki Y; Ozono K; Sakai N
    Brain Dev; 2016 Feb; 38(2):175-80. PubMed ID: 26259553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
    Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
    Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.
    Furuya H; Kukita Y; Nagano S; Sakai Y; Yamashita Y; Fukuyama H; Inatomi Y; Saito Y; Koike R; Tsuji S; Fukumaki Y; Hayashi K; Kobayashi T
    Hum Genet; 1997 Sep; 100(3-4):450-6. PubMed ID: 9272171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones.
    Spratley SJ; Deane JE
    J Neurosci Res; 2016 Nov; 94(11):1203-19. PubMed ID: 27638604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
    Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
    J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants.
    Spratley SJ; Hill CH; Viuff AH; Edgar JR; Skjødt K; Deane JE
    Traffic; 2016 Aug; 17(8):908-22. PubMed ID: 27126738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical chaperone therapy: luciferase assay for screening of β-galactosidase mutations.
    Li L; Higaki K; Ninomiya H; Luan Z; Iida M; Ogawa S; Suzuki Y; Ohno K; Nanba E
    Mol Genet Metab; 2010 Dec; 101(4):364-9. PubMed ID: 20826101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel homozygous GALC mutation: very early onset and rapidly progressive Krabbe disease.
    Kardas F; Uzak AS; Hossain MA; Sakai N; Canpolat M; Yıkılmaz A
    Gene; 2013 Mar; 517(1):125-7. PubMed ID: 23276707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.
    Zhuang S; Kong L; Li C; Chen L; Zhang T
    BMC Neurol; 2019 Jun; 19(1):122. PubMed ID: 31185936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast screening for chaperone therapy in beta-galactosidosis.
    Iwasaki H; Watanabe H; Iida M; Ogawa S; Tabe M; Higaki K; Nanba E; Suzuki Y
    Brain Dev; 2006 Sep; 28(8):482-6. PubMed ID: 16617000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four novel GALC gene mutations in two Chinese patients with Krabbe disease.
    Yang Y; Ren X; Xu Q; Wang C; Liu H; He X
    Gene; 2013 May; 519(2):381-4. PubMed ID: 23462331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.